Do publicly supported generic pharmacies improve financial risk protection? Findings from a nationally representative cross-sectional survey in India
Neha Purohit, Aarti Goyal, Gaurav Jyani, Biju Soman, Sitanshu Sekhar Kar, Ramesh Verma, Kuldeep Singh, Sandra Albert, Prakash Patel, Saroj Kumar Rana, Sanjay Kumar, Sashi Bushan Biswal, Shankar Prinja · 2026
Read Do publicly supported generic pharmacies improve financial risk protection? Findings from a nationally representative cross-sectional survey in India by Neha Purohit, Aarti Goyal, Gaurav Jyani, Biju Soman, Sitanshu Sekhar Kar, Ramesh Verma, Kuldeep Singh, Sandra Albert, Prakash Patel, Saroj Kumar Rana, Sanjay Kumar, Sashi Bushan Biswal, Shankar Prinja (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13182323.txt.
Description
Neha Purohit and co-authors asked whether India's public generic drug stores guard family budgets in a 2026 survey study. The scheme backs low-price generic shops, Jan Aushadhi Kendras, to cut the cost of medicines. High drug bills push many Indian families into debt or poverty each year.
Their survey was nationally drawn and cross-sectional, run across nine states in 2022 and 2023. They read out-of-pocket drug spend, ruinous health spend, and poverty caused by medicine costs. Users of the scheme were set against the rest. The results judge whether cheap generics truly soften the blow of illness.
Catalog record
| CREATOR | Neha Purohit, Aarti Goyal, Gaurav Jyani, Biju Soman, Sitanshu Sekhar Kar, Ramesh Verma, Kuldeep Singh, Sandra Albert, Prakash Patel, Saroj Kumar Rana, Sanjay Kumar, Sashi Bushan Biswal, Shankar Prinja |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 47 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |